Model | Adult/Neonate | Dosage (μg/kg) | Application/Duration | Outcome | Ref |
---|---|---|---|---|---|
Acute ischaemic cerebral injury (MCAO) | Adult SD rats | 100 | s.c. injected immediately after injury for 7d | Reduced infarct volume & necrotic cells | [29] |
Increased Egr-1 & VEGF expression levels | |||||
Stroke (BCAO) | adult male Swiss Webster mice | 50 | s.c. injected 30min afterocclusion for 4 to 7 consecutive days | Increased expression of G-CSF receptor | [36] |
Decreased GRP78 expression & decreased ATF6 cleavage levels | |||||
Decreased apoptotic protein signalling (DRI1 & P53) & increased pro-survival signalling (OPAI) | |||||
Upregulated anti-apoptotic protein Bcle-2 and downregulated pro-apoptotic proteins Bax & Bak | |||||
Increased locomotor sensitisation | |||||
Cerebral ischaemia reperfusion (tMCAO) | Adult SD rats | 50 | s.c. injected 1h after restoring CBF for 5 consecutive days | Reduced infarct volume & oedema | [37] |
Improved neurological function & reduced apoptotic neurons | |||||
Downregulated the activation of the JNK apoptosis pathway | |||||
Ischaemic brain injury (DHCA) | Newborn piglets | 34 | iv. 2h prior to inintiation of bypass | Reduced neuronal injury in the hippocampus | [38] |
Focal cerebral ischaemia (MCAO) | Adult male SD rats | 50 | s.c. injected at the onset of reperfusion; 2nd injected at onset of reperfusion for 2d | Attenuated infarct volume & early neurological deficits | [39] |
Elevated STAT3 phosphorylation & nuclear Pim-1 expression | |||||
Increased expression of cIAP2 & Bcl-2 & decreased caspase-3 & Bax levels | |||||
Hypoxia-ischaemia (RCCA ligation) | Neonatal SD rats | 50 | s.c. injected 1h after HI for 56 | Less vacuolization, neuron loss & tissue breakqown | [33] |
Increased brain weight & G-CSF receptor expression | |||||
Reduced cleaved caspase-3 activity | |||||
Increased expression of anti-apoptotic pathway mediators | |||||
Hypoxic-ischaemic brain damage (RCCA ligation) | Neonatal SD rats | 50 | s.c. injected 1h after HI for 6 days & 11 days | Promoted physical development & improved functional deficits | [40] |
Reduced brain atrophy & increased systemic organ weight | |||||
Increased exploratory behaviour & shorm-term memory | |||||
Hypoxia- ischaemia (RCCA ligation) | Neonatal SD rat pups | 50 | s.c. injected 1h after HI | Reduced infarct volume & corticosterone levels | [41] |
Decreased cleaved caspase-3 level & lowered Bax/Bcl-2 ratio | |||||
G-CSF did not influence ACTH response | |||||
Hypoxia- ischaemia (RCCA ligation) | Neonatal SD rat pups | 50 | s.c. or i.p. 1h after HI for 4d | Reduced infarct volume & lung injury | [30] |
Increased neutrophil count & less brain tissue atrophy | |||||
Improved physical development & neurological function | |||||
Hypoxia-ischaemia (RCCA ligation) | Neonatal SD rat pups | 50 | s.c. injected 1h after HI | Reduced infarct volume & increased expression of G-CSF receptor in neurons | [42] |
Increased p-AKt expression & decreased p-GSK-3β/GSK-3β ratio | |||||
Decreased aopototic markers & TUNEL positice cells in neuron | |||||
Perinatal hypoxia | Neonatal SD rat pups | 10, 30, 50 | s.c. injected 1d after HI | Attenuated PSD-95 protein expression levels & improved long-term deficits | [43] |
Increased phosphorylated activity of pRaf-pERK1/2-PCREB pathway | |||||
Enhanced increase expression of neurogenesis in hippocampal neuron | |||||
Stroke (MCA ligation) | Adult male SD rats | 15 | s.c. injected 1h after restoring CBF for 15d | Decreased mortality rate & less effect in reducing infarct volume | [44] |
Improved functional recovery of motor function | |||||
Increased number of proliferating cells & new neurons in the SVZ | |||||
Hypoxia-ischaemia (RCCA ligation) | Neonatal SD rats | 50 | i.p. immediately after HI induction | Attenuated cerebral infarction & improved body weight | [45] |
Inhibited apoptosis by decreasing apoptotic cells & increased brain volume | |||||
Focal cerebral ischaemia (MCAO) | Male Wistar rats | 60 | iv 30min after occlusion | Reduced infarct volume & mortality rate | [46] |
Increased STAT3 expression & anti-excitotoxic effect | |||||
Stroke (MCAO/CCA) | Â | 50 | iv 60min after induction | Elevated neutrophil count & reduced infarct volume | [47] |
Increased expression of G-CSF receptor in neurons | |||||
(MCAO) | Â | 60 | iv 2h after onset of occlusion for 5d | Increased protein level of STAT3 & increased AKt phosphorylation | |
Improved long-term behaviour | |||||
Hypoxic-ischaemic brain injury (MCAO) | Neonatal mice pups | 200 | s.c. injected 1h after injury & 60h after injury for 5d | Did not improved neurobehavioural outcomes & brain injuries | [48] |
Perinatal hypoxia | Neonatal rat pups | 30 | i.p. 1d after HI induction for 6d | Enhanced neurogenesis & improved long-term cognitive function | [49] |
Hypoxia- ischaemia (RCCA ligation) | Neonatal SD rat pups | 50 | i.p. 2.5h after HI induction | Decreased expression levels of TNF-α and IL-1β & increased IL-10 levelsDecreased expression levels of TNF-α and IL-1β & increased IL-10 levels | [50] |
Increased Bcl-2 expression levels & decreased CC3 and Bax expression levels | |||||
Upregulated p-mTOR and p-P70S6K protein expression levels | |||||
Hypoxia-ischaemia (RCCA ligation) | Neonatal SD rat pups | 50 | s.c. injected 1h after HI | Showed localisation of G-CSF receptor in enthothial cells | [51] |
Decreased β-catenin and p120-catenin phosphorylationDecreased β-catenin and p120-catenin phosphorylation | |||||
Attenuated PICs (IKKβ, NF-κB, TNF-α, IL-1β) & enhanced IL-10 levelsAttenuated PICs (IKKβ, NF-κB, TNF-α, IL-1β) & enhanced IL-10 levels | |||||
Decreased adheren proteins & increased tight junction proteins expression | |||||
Hypoxia-ischaemia (RCCA ligation) | Neonatal SD rat pups | 50 | s.c. injected 1h after hypoxia | Inhibited corticosterone synthesis by activating its receptor in cortical cells | [52] |
Increased expression of JAK2, PI3K, AKt and PDE3B proteins | |||||
Inhibited cAMP elevation induced by cholera toxin | |||||
Decreased infarct volume and increased body weight |